It has the ability to specifically target liver cancer cell and the anti-GPC3 Ab were combined with nanoparticles (NPs), an AB-SFB-NP nano-drug delivery system with large drug loading capacity, good targeting, high safety, stable, and controllable drug release rate in the tumor was constructed [11]. Here, GPC3 is linked to neoplasm.